Litcius/Paper detail

A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice

Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Mamie T. Coats, Guillermo H. Giambartolomei, Shree R. Singh, Vida A. Dennis

2020Nanomedicine Nanotechnology Biology and Medicine28 citationsDOIOpen Access PDF

Topics & Concepts

PLGACD86CD80Priming (agriculture)AntigenImmune systemCD40Cell biologyDendritic cellBiologyT cellImmunologyIn vitroCytotoxic T cellBiochemistryBotanyGerminationImmunotherapy and Immune ResponsesT-cell and B-cell ImmunologyReproductive System and Pregnancy
A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice | Litcius